Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABX-EGF in Hormone Resistant Prostate Cancer
NCT00054574Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Nov 2002
- Primary completion
- Sep 2003
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in prostate cancer (PCa), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Nov 2002; status: completed.
02
Drugs
panitumumab
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00054574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00054574.